Bloomage BioTech CEO eyes takeovers

Xuekun Jin, chief executive of the Hong Kong-listed Chinese company, talks to FinanceAsia about his plans.
March 23, 2017

Chinese cosmetics and biomedical company Bloomage BioTech, is on the lookout for acquisitions, chief executive Xuekun Jin told FinanceAsia on Thursday.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media